Anaplasma phagocytophilum (HGE) Antibody, IgG and IgM, IFA
Synonyms
- Anaplasma phagocytophilum
- Ehrlichia
- HGE
- Tickborne
|
|
Expected Turnaround Time
1 - 4 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Related Documents
Specimen Requirements
Specimen
Serum
Volume
0.4 mL
Minimum Volume
0.2 mL
Container
Red-top tube or gel-barrier tube or serum transfer tube
|
Red-top tube or gel-barrier tube |
|
Red-top tube or gel-barrier tube or serum transfer tube |
Collection
Specimen should be free of bacterial contamination, hemolysis, and lipemia.
Storage Instructions
Refrigerate.
|
Refrigerate |
|
Refrigerate. |
Causes for Rejection
Hemolysis; lipemia; gross bacterial contamination
Test Details
Use
This test is used for detection and semiquantitation of serum IgG and IgM antibodies to Anaplasma phagocytophilum (HGE) to aid in the diagnosis of human granulocytic ehrlichiosis.
Confirmation of diagnosis is based on laboratory testing, but antibiotic therapy should not be delayed in patients with a suggestive clinical presentation. The diagnosis of acute anaplasmosis cannot be confirmed solely by the presence of antibodies in a serum sample collected at a single timepoint. DNA PCR can be used to diagnose acute infection. Demonstration of a 4-fold rise in IgG-specific antibody titers by IFA in paired samples (acute and convalescent) confirms infection with A. phagocytophilum. IgM antibodies are less specific than IgG antibodies and are more likely to generate false positive results. IgM results alone should not be used for laboratory diagnosis. Antibody titers are frequently negative during the first 7-10 days of illness.
|
This test is used for detection and semiquantitation of serum IgG and IgM antibodies to Anaplasma phagocytophilum (HGE) to aid in the diagnosis of human granulocytic ehrlichiosis. <s. |
|
This test is used for detection and semiquantitation of serum IgG and IgM antibodies to Anaplasma phagocytophilum (HGE) to aid in the diagnosis of human granulocytic ehrlichiosis. Confirmation of diagnosis is based on laboratory testing, but antibiotic therapy should not be delayed in patients with a suggestive clinical presentation. The diagnosis of acute anaplasmosis cannot be confirmed solely by the presence of antibodies in a serum sample collected at a single timepoint. DNA PCR can be used to diagnose acute infection. Demonstration of a 4-fold rise in IgG-specific antibody titers by IFA in paired samples (acute and convalescent) confirms infection with A. phagocytophilum. IgM antibodies are less specific than IgG antibodies and are more likely to generate false positive results. IgM results alone should not be used for laboratory diagnosis. Antibody titers are frequently negative during the first 7-10 days of illness. |
Limitations
The diagnosis of acute anaplasmosis cannot be confirmed solely by the presence of Anaplasma antibody in a serum sample collected at a single time point.
|
|
|
The diagnosis of acute anaplasmosis cannot be confirmed solely by the presence of Anaplasma antibody in a serum sample collected at a single time point. |
Methodology
Indirect fluorescent antibody (IFA)
Reference Interval
• IgG negative: <1:64
• IgM negative: <1:20
References
|
|
|
Centers for Disease Control and Prevention (CDC). Tickborne Diseases of the United States: A reference manual for healthcare providers. Sixth edition. 2022. CDC website: https://www.cdc.gov/ticks/tickbornediseases/index.html. Accessed May 2023. |
LOINC® Map
| Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
|---|---|---|---|---|---|---|
| 164672 | Anaplasma phagocytophilum Ab | 55150-7 | 164674 | A. phagocytophilum IgG | 23877-4 | |
| 164672 | Anaplasma phagocytophilum Ab | 55150-7 | 164667 | A. phagocytophilum IgM | 23878-2 |
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf